G-CSF Boosts Bone Marrow Cell Therapy for Stroke in Mice
Author Information
Author(s): Zhang Xue-Mei, Du Fang, Yang Dan, Wang Rui, Yu Chun-Jiang, Huang Xiang-Nan, Hu Hong-Yan, Liu Wei, Fu Jin
Primary Institution: Second Affiliated Hospital, Harbin Medical University
Hypothesis
Can G-CSF improve the therapeutic efficacy of bone marrow mononuclear cell transplantation in cerebral ischemia?
Conclusion
G-CSF enhances the effectiveness of BMMC transplantation, leading to reduced brain damage and improved recovery in mice with cerebral ischemia.
Supporting Evidence
- The infarct size was significantly smaller in the BMMCs+G-CSF group compared to other treatment groups.
- BMMCs and G-CSF co-administration improved neurological function recovery over time.
- Increased proliferation of bone marrow stem cells was observed in the presence of G-CSF.
Takeaway
This study shows that giving a special protein called G-CSF along with bone marrow cells helps mice recover better from a brain injury.
Methodology
Mice with cerebral ischemia received BMMC transplantation with or without G-CSF, and their recovery was assessed through infarct size and neurological function tests.
Participant Demographics
Inbred BALB/c mice, 8 to 10 weeks old, male or female.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p < 0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website